Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G O Potts

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Endocrinology|February 1, 1971
Unique estrogen-binding properties of rat pregnancy plasmaM S Soloff, J E Creange, G O Potts
Fertility and Sterility|September 1, 1978
Interceptive activity of azastene in rhesus monkeysH P Schane, J E Creange, A J Anzalone, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 1, 1984
Inhibition of furosemide-induced kaliuresis in the rat by trilostane, an inhibitor of adrenal steroidogenesisH R Harding, J E Creange, G O Potts, et al.
Contraception|September 1, 1981
Win 32,729, a new, potent interceptive agent in rats and rhesus monkeysJ E Creange, A J Anzalone, G O Potts, et al.
Journal of Medicinal Chemistry|September 1, 1970
Steroidal heterocycles. 13. 4alpha,5-Epoxy-5alpha-androst-2-eno[2,3-d]isoxazoles and related compoundsH C Neumann, G O Potts, W T Ryan, et al.
Fertility and Sterility|July 1, 1978
Interruption of pregnancy in rats by azastene, an inhibitor of ovarian and adrenal steroidogenesisJ E Creange, H P Schane, A J Anzalone, et al.
Steroids|September 1, 1978
Trilostane, an orally active inhibitor of steroid biosynthesisG O Potts, J E Creange, H R Hardomg, et al.
Journal of Medicinal Chemistry|July 1, 1970
Basic ethers of 1-(p-hydroxyphenyl)-2-phenyl-1,2,3,4-tetrahydroquinoline and 1-(p-hydroxyphenyl)-2-pehnylindole. Antifertility agentsM R Bell, A W Zalay, R Oesterlin, et al.
Fertility and Sterility|June 1, 1983
Inhibition of human placental progesterone synthesis and aromatase activity by synthetic steroidogenic inhibitors in vitroT Rabe, L Kiesel, J Kellermann, et al.
Agents and Actions|August 1, 1988
The effect of danazol in the MRL/lpr mouse model of autoimmune diseaseK M Connolly, V J Stecher, B W Snyder, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Endocrinology|February 1, 1971
Unique estrogen-binding properties of rat pregnancy plasmaM S Soloff, J E Creange, G O Potts
Fertility and Sterility|September 1, 1978
Interceptive activity of azastene in rhesus monkeysH P Schane, J E Creange, A J Anzalone, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 1, 1984
Inhibition of furosemide-induced kaliuresis in the rat by trilostane, an inhibitor of adrenal steroidogenesisH R Harding, J E Creange, G O Potts, et al.
Contraception|September 1, 1981
Win 32,729, a new, potent interceptive agent in rats and rhesus monkeysJ E Creange, A J Anzalone, G O Potts, et al.
Journal of Medicinal Chemistry|September 1, 1970
Steroidal heterocycles. 13. 4alpha,5-Epoxy-5alpha-androst-2-eno[2,3-d]isoxazoles and related compoundsH C Neumann, G O Potts, W T Ryan, et al.
Fertility and Sterility|July 1, 1978
Interruption of pregnancy in rats by azastene, an inhibitor of ovarian and adrenal steroidogenesisJ E Creange, H P Schane, A J Anzalone, et al.
Steroids|September 1, 1978
Trilostane, an orally active inhibitor of steroid biosynthesisG O Potts, J E Creange, H R Hardomg, et al.
Journal of Medicinal Chemistry|July 1, 1970
Basic ethers of 1-(p-hydroxyphenyl)-2-phenyl-1,2,3,4-tetrahydroquinoline and 1-(p-hydroxyphenyl)-2-pehnylindole. Antifertility agentsM R Bell, A W Zalay, R Oesterlin, et al.
Fertility and Sterility|June 1, 1983
Inhibition of human placental progesterone synthesis and aromatase activity by synthetic steroidogenic inhibitors in vitroT Rabe, L Kiesel, J Kellermann, et al.
Agents and Actions|August 1, 1988
The effect of danazol in the MRL/lpr mouse model of autoimmune diseaseK M Connolly, V J Stecher, B W Snyder, et al.
Pageof 3